Incannex Healthcare (NASDAQ:IXHL) Posts Earnings Results

Incannex Healthcare (NASDAQ:IXHL) announced its quarterly earnings results on Friday. The company reported ($0.33) earnings per share for the quarter, Zacks reports.

Incannex Healthcare Stock Performance

Shares of Incannex Healthcare stock traded down $0.03 on Friday, reaching $1.77. 37,933 shares of the company were exchanged, compared to its average volume of 86,808. The company’s 50-day moving average is $1.85 and its two-hundred day moving average is $1.92. The firm has a market cap of $31.22 million, a price-to-earnings ratio of -1.28 and a beta of 7.44. Incannex Healthcare has a 1-year low of $1.50 and a 1-year high of $8.47.

About Incannex Healthcare

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.